SciBase Holding AB (OSTO:SCIB) Buyback Yield %: -31.89 (As of Jul. 04, 2026)


OSTO:SCIB SciBase Holding AB OSTO:SCIB
50 GF Score
Price kr33.80
GF Value kr21.74
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is SciBase Holding AB Buyback Yield %?

SciBase Holding AB OSTO:SCIB +0.30% 50 Buyback Yield % is -31.89 as of Jul. 04, 2026. GuruFocus rates OSTO:SCIB with a GF Score™ of 50/100 and a GF Value™ of kr21.74 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 347 Medical Devices & Instruments companies, SciBase Holding AB ranks worse than 84.44% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

SciBase Holding AB's current buyback yield was -31.89%.


SciBase Holding AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for SciBase Holding AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciBase Holding AB Buyback Yield % Chart

SciBase Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.83 0.00 -79.65 -46.53 -58.64

SciBase Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -67.08 -47.05 -53.24 -58.64 -30.80

OSTO:SCIB vs ABT, SYK, MDT: Buyback Yield % Comparison

For the Medical Devices subindustry, SciBase Holding AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's Buyback Yield % falls into.


OSTO:SCIB
50GF Score
SciBase Holding AB OSTO:SCIB
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SciBase Holding AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

SciBase Holding AB's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 83.796) / 142.8875
=-58.64%

SciBase Holding AB's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 110.209) / 357.875
=-30.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -31.89 mean?
SciBase Holding AB (OSTO:SCIB) has a Buyback Yield % of -31.89 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SciBase Holding AB and its competitors. According to the industry distribution chart, SciBase Holding AB ranks #293 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 84.4%.
Is SciBase Holding AB's Buyback Yield % too high?
SciBase Holding AB's current Buyback Yield % is -31.89. Based on the distribution chart, SciBase Holding AB ranks #293 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SciBase Holding AB has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SciBase Holding AB ranks #293 out of 347 companies for Buyback Yield %. This places SciBase Holding AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SciBase Holding AB and its competitors. SciBase Holding AB's current Buyback Yield % is -31.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
Based on GuruFocus' analysis, SciBase Holding AB (OSTO:SCIB) is currently considered Significantly Overvalued. The stock's GF Value™ is kr21.74, compared to a current price of kr33.80 — trading 55.5% above its estimated fair value. The current Buyback Yield % is -31.89. SciBase Holding AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For SciBase Holding AB (OSTO:SCIB), the current Buyback Yield % is -31.89 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SciBase Holding AB (OSTO:SCIB) Overvalued in 2026?

Based on GuruFocus' analysis, SciBase Holding AB stock appears to be overvalued. The current stock price of kr33.80 is trading 55.5% above its estimated GF Value™ of kr21.74. GuruFocus considers SciBase Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:SCIB:

  • Buyback Yield %: -31.89
  • GF Value™: kr21.74 vs. price of kr33.80 (55.5% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SCIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SciBase Holding AB Business Description

Address Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
50GF Score

Get the complete analysis for OSTO:SCIB

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr33.80
Price
kr21.74
GF Value